The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Funding rounds indicate market confidence and shape which platforms will have resources for long-term development. Tracking these signals helps teams evaluate vendor stability and ecosystem health.
StrictlyVC joins TechCrunch Disrupt 2026 to discuss the changing VC landscape thanks to AI. Get your Investor Pass to join these exclusive sessions.
Ema has raised $140 million to date and has more than 50 enterprise customers, including Google and Microsoft.
The seven-year-old startup has raised a $350 million Series E to fuel its data-as-a-service approach.
